<DOC>
	<DOC>NCT01051232</DOC>
	<brief_summary>A single dose of PF-00868554 (filibuvir) will be safety and tolerable in Japanese healthy volunteers. The pharmacokinetics in Japanese will be consistent to that available in Western population.</brief_summary>
	<brief_title>A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers</brief_title>
	<detailed_description>Investigation of safety, tolerability and pharmacokinetics of single oral administration of PF-00868554 (filibuvir) in healthy adult Japanese volunteers.</detailed_description>
	<criteria>Healthy male and female subjects between the ages of 20 and 55 years. Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg. A positive result for Hepatitis B surface antigen (HbsAg) or antihepatitis C virus serology, and HIV antigen/antibody. Male subjects with a history of subfertility/infertility and other conditions that in the opinion of the investigator may affect fertility. Pregnant or nursing females; females of childbearing potential.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>filibuvir</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Japanese</keyword>
	<keyword>Asian</keyword>
</DOC>